Use of platinum-based neoadjuvant chemotherapy (NACT) in patients (pts) with hormone receptor-positive breast cancer.

被引：0
|
作者：
Kyriakopoulos, Christos
Ambros, Tadeu Frantz
Montero, Alberto J.
Hurley, Judith
机构：
[1] Univ Miami, Miami, FL USA
[2] Univ Miami, Jackson Mem Hosp, Miami, FL 33136 USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11038
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effectiveness of platinum-based chemotherapy for hormone receptor-positive HER2-negative metastatic breast cancer
    Uratani, Lucas Fernando
    Bermejo, Francesco Sansone
    Hashizume, Pedro HenriqueShimiti
    Bonadio, Renata Colombo
    Testa, Laura
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [2] Predictors of response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer.
    Moore, Halle C. F.
    Maiti, Baidehi
    Rybicki, Lisa A.
    Booth, Christine
    Abraham, Jame
    Budd, G. Thomas
    Andresen, Steven Ware
    Downs-Kelly, Erinn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Outcome of neoadjuvant-treated young patients with hormone receptor-positive breast cancer.
    Mayte Villarreal-Garza, Cynthia
    Arce-Salinas, Claudia
    Lasa, Federico
    Reynoso, Nancy
    Antonio Matus, Juan
    Lara-Medina, Fernando
    Bargallo-Rocha, Enrique
    Flores Diaz, Diana Fabiola
    Shaw, Robin J.
    Alvarado-Miranda, Alberto
    Jaime Castaneda, Noel
    Alejandra Martinez-Cannon, Bertha
    Mohar, Alejandro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy
    Seber, Erdogan Selcuk
    Iriagac, Yakup
    Cavdar, Eyyup
    Karaboyun, Kubilay
    Avci, Okan
    Yolcu, Ahmet
    Gurdal, Sibel Oezkan
    Oznur, Meltem
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (03): : 434 - 439
  • [5] Methods for selection of neoadjuvant treatment with chemotherapy for patients with hormone receptor-positive and HER2-negative with early breast cancer.
    Gasol Cudos, Ariadna
    Morales Murillo, Serafin
    Tuset Der-abrain, Noemi
    Arbones Cid, Laura
    Morera Morillo, Ester
    Vilardell, Felip
    Sanchez Guzman, Douglas
    Canosa Morales, Carles
    Mele Olive, Jordi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Is controlled ovarian stimulation safe in patients with hormone receptor-positive breast cancer receiving neoadjuvant chemotherapy?
    Benvenuti, C.
    Laot, L.
    Grinda, T.
    Lambertini, M.
    Pistilli, B.
    Grynberg, M.
    [J]. ESMO OPEN, 2024, 9 (02)
  • [7] Proteomic prediction in hormone receptor-positive breast cancer.
    Hennessy, B. T.
    Gonzalez-Angulo, A. M.
    Lu, Y.
    Tibes, R.
    Siwak, D.
    Sahin, A.
    Kau, S.
    Hortobagyi, G. N.
    Valero, V.
    Mills, G. B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 13S - 13S
  • [8] Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor-positive Breast Cancer
    Chen, Sheng
    Chen, Can-Ming
    Yu, Ke-Da
    Zhou, Ruo-Ji
    Shao, Zhi-Ming
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (09) : 3002 - 3011
  • [9] Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study
    Michael Zeidman
    J. Jaime Alberty-Oller
    Meng Ru
    Kereeti V. Pisapati
    Erin Moshier
    Soojin Ahn
    Madhu Mazumdar
    Elisa Port
    Hank Schmidt
    [J]. Breast Cancer Research and Treatment, 2020, 184 : 203 - 212
  • [10] Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study
    Zeidman, Michael
    Alberty-Oller, J. Jaime
    Ru, Meng
    Pisapati, Kereeti V.
    Moshier, Erin
    Ahn, Soojin
    Mazumdar, Madhu
    Port, Elisa
    Schmidt, Hank
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (01) : 203 - 212
12345